diphtheria, tetanus, and poliovirus vaccine
Vaccineexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
1
Phase 4
0
Earliest trial started Feb 1, 2007 (NCT00447525)
Timeline
Indications
Mechanism of action
- Tetanus toxinImmunity, active
tetX immunity, active
- PoliovirusImmunity, active
Poliovirus immunity, active
- Diphtheria toxinImmunity, active
Diphtheria toxin immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- dt polio
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04099303 | Phase 1 | Dec 20, 2019 | Government of China, Tianjin Cansino Biotechnology Inc |
| NCT00447525 | Phase 3 | Feb 1, 2007 | Sanofi-Aventis |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Government of China | Government | 1 | 0 | 1 | 2019 |
| Sanofi-Aventis | For profit | 1 | 1 | 1 | 2007 |
| Tianjin Cansino Biotechnology Inc | For profit | 1 | 1 | 1 | 2019 |
3 organizations
Page 1 / 1